- Home
- AVPT vs SRRK Comparison
AVPT vs SRRK Comparison
Compare AVPT & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVPT
- SRRK
- Stock Information
- Founded
- AVPT 2001
- SRRK 2012
- Country
- AVPT United States
- SRRK United States
- Employees
- AVPT N/A
- SRRK N/A
- Industry
- AVPT Computer Software: Prepackaged Software
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AVPT Technology
- SRRK Health Care
- Exchange
- AVPT Nasdaq
- SRRK Nasdaq
- Market Cap
- AVPT 3.0B
- SRRK 2.9B
- IPO Year
- AVPT N/A
- SRRK 2018
- Fundamental
- Price
- AVPT $14.43
- SRRK $30.75
- Analyst Decision
- AVPT Buy
- SRRK Strong Buy
- Analyst Count
- AVPT 4
- SRRK 6
- Target Price
- AVPT $15.75
- SRRK $42.17
- AVG Volume (30 Days)
- AVPT 1.1M
- SRRK 1.6M
- Earning Date
- AVPT 05-08-2025
- SRRK 05-06-2025
- Dividend Yield
- AVPT N/A
- SRRK N/A
- EPS Growth
- AVPT N/A
- SRRK N/A
- EPS
- AVPT N/A
- SRRK N/A
- Revenue
- AVPT $330,482,000.00
- SRRK N/A
- Revenue This Year
- AVPT $18.87
- SRRK N/A
- Revenue Next Year
- AVPT $18.84
- SRRK $601.05
- P/E Ratio
- AVPT N/A
- SRRK N/A
- Revenue Growth
- AVPT 21.58
- SRRK N/A
- 52 Week Low
- AVPT $7.62
- SRRK $6.76
- 52 Week High
- AVPT $19.90
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- AVPT 46.37
- SRRK 49.04
- Support Level
- AVPT $14.08
- SRRK $28.79
- Resistance Level
- AVPT $14.89
- SRRK $31.09
- Average True Range (ATR)
- AVPT 0.73
- SRRK 2.50
- MACD
- AVPT 0.12
- SRRK 0.44
- Stochastic Oscillator
- AVPT 69.29
- SRRK 78.82
About AVPT AvePoint Inc.
AvePoint Inc provides customizable solutions to optimize SaaS operations, enable secure collaboration, and accelerate digital transformation across technologies and industries. Its Confidence Platform delivers a comprehensive set of cloud-based solutions enabling IT operations, development operations, and cybersecurity professionals to monitor and secure the digital workplace using SaaS tools.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.